Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events

Background The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) have not been assessed. Therefore, we aimed to assess its validity, reliability, and responsiveness. Patients and method...

Full description

Saved in:
Bibliographic Details
Published inBMC cancer Vol. 21; no. 1; pp. 1 - 11
Main Authors Yang, Shan-Shan, Chen, Lei, Liu, Ying, Lu, Hai-Jun, Huang, Bo-Jie, Lin, Ai-Hua, Sun, Ying, Ma, Jun, Xie, Fang-Yun, Mao, Yan-Ping
Format Journal Article
LanguageEnglish
Published London BioMed Central Ltd 27.07.2021
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) have not been assessed. Therefore, we aimed to assess its validity, reliability, and responsiveness. Patients and methods A Chinese version of the PRO-CTCAE and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (QLQ-C30) were distributed to 1580 patients from four cancer hospitals in China. Validity assessments included construct validity, measured by Pearson's correlations and confirmatory factor analysis (CFA), and known-groups validity, measured by t-tests. The assessment of reliability included internal consistency, measured by Cronbach's É, and test-retest reliability, measured by the intraclass correlation (ICC). Responsiveness was assessed by standardized response means (SRMs). Results Data from 1555 patients who completed the instruments were analyzed. The correlations were high between PRO-CTCAE items and parallel QLQ-C30 symptom scales (r > 0.60, p < 0.001), except for fatigue (severity: r = 0.49). Moreover, CFA showed the PRO-CTCAE structure was a good fit with the data (Root Mean Square Error of Approximation = 0.046). Known-groups validity was also confirmed. Cronbach's É of all item clusters were greater than 0.9 and the median test-retest reliability coefficients of the 38 items were 0.85 (range = 0.71-0.91). In addition, the SRMs of PRO-CTCAE items were greater than 0.8, indicating strong responsiveness. Conclusion The simplified Chinese version of the PRO-CTCAE showed good reliability, validity, and responsiveness. Keywords: Patient-reported outcomes, PRO-CTCAE, Chinese, Validity, Reliability
AbstractList The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) have not been assessed. Therefore, we aimed to assess its validity, reliability, and responsiveness.BACKGROUNDThe psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) have not been assessed. Therefore, we aimed to assess its validity, reliability, and responsiveness.A Chinese version of the PRO-CTCAE and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (QLQ-C30) were distributed to 1580 patients from four cancer hospitals in China. Validity assessments included construct validity, measured by Pearson's correlations and confirmatory factor analysis (CFA), and known-groups validity, measured by t-tests. The assessment of reliability included internal consistency, measured by Cronbach's ɑ, and test-retest reliability, measured by the intraclass correlation (ICC). Responsiveness was assessed by standardized response means (SRMs).PATIENTS AND METHODSA Chinese version of the PRO-CTCAE and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (QLQ-C30) were distributed to 1580 patients from four cancer hospitals in China. Validity assessments included construct validity, measured by Pearson's correlations and confirmatory factor analysis (CFA), and known-groups validity, measured by t-tests. The assessment of reliability included internal consistency, measured by Cronbach's ɑ, and test-retest reliability, measured by the intraclass correlation (ICC). Responsiveness was assessed by standardized response means (SRMs).Data from 1555 patients who completed the instruments were analyzed. The correlations were high between PRO-CTCAE items and parallel QLQ-C30 symptom scales (r > 0.60, p < 0.001), except for fatigue (severity: r = 0.49). Moreover, CFA showed the PRO-CTCAE structure was a good fit with the data (Root Mean Square Error of Approximation = 0.046). Known-groups validity was also confirmed. Cronbach's ɑ of all item clusters were greater than 0.9 and the median test-retest reliability coefficients of the 38 items were 0.85 (range = 0.71-0.91). In addition, the SRMs of PRO-CTCAE items were greater than 0.8, indicating strong responsiveness.RESULTSData from 1555 patients who completed the instruments were analyzed. The correlations were high between PRO-CTCAE items and parallel QLQ-C30 symptom scales (r > 0.60, p < 0.001), except for fatigue (severity: r = 0.49). Moreover, CFA showed the PRO-CTCAE structure was a good fit with the data (Root Mean Square Error of Approximation = 0.046). Known-groups validity was also confirmed. Cronbach's ɑ of all item clusters were greater than 0.9 and the median test-retest reliability coefficients of the 38 items were 0.85 (range = 0.71-0.91). In addition, the SRMs of PRO-CTCAE items were greater than 0.8, indicating strong responsiveness.The simplified Chinese version of the PRO-CTCAE showed good reliability, validity, and responsiveness.CONCLUSIONThe simplified Chinese version of the PRO-CTCAE showed good reliability, validity, and responsiveness.
The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) have not been assessed. Therefore, we aimed to assess its validity, reliability, and responsiveness. A Chinese version of the PRO-CTCAE and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (QLQ-C30) were distributed to 1580 patients from four cancer hospitals in China. Validity assessments included construct validity, measured by Pearson's correlations and confirmatory factor analysis (CFA), and known-groups validity, measured by t-tests. The assessment of reliability included internal consistency, measured by Cronbach's É, and test-retest reliability, measured by the intraclass correlation (ICC). Responsiveness was assessed by standardized response means (SRMs). Data from 1555 patients who completed the instruments were analyzed. The correlations were high between PRO-CTCAE items and parallel QLQ-C30 symptom scales (r > 0.60, p < 0.001), except for fatigue (severity: r = 0.49). Moreover, CFA showed the PRO-CTCAE structure was a good fit with the data (Root Mean Square Error of Approximation = 0.046). Known-groups validity was also confirmed. Cronbach's É of all item clusters were greater than 0.9 and the median test-retest reliability coefficients of the 38 items were 0.85 (range = 0.71-0.91). In addition, the SRMs of PRO-CTCAE items were greater than 0.8, indicating strong responsiveness. The simplified Chinese version of the PRO-CTCAE showed good reliability, validity, and responsiveness.
Abstract Background The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) have not been assessed. Therefore, we aimed to assess its validity, reliability, and responsiveness. Patients and methods A Chinese version of the PRO-CTCAE and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (QLQ-C30) were distributed to 1580 patients from four cancer hospitals in China. Validity assessments included construct validity, measured by Pearson’s correlations and confirmatory factor analysis (CFA), and known-groups validity, measured by t-tests. The assessment of reliability included internal consistency, measured by Cronbach’s ɑ, and test-retest reliability, measured by the intraclass correlation (ICC). Responsiveness was assessed by standardized response means (SRMs). Results Data from 1555 patients who completed the instruments were analyzed. The correlations were high between PRO-CTCAE items and parallel QLQ-C30 symptom scales (r > 0.60, p < 0.001), except for fatigue (severity: r = 0.49). Moreover, CFA showed the PRO-CTCAE structure was a good fit with the data (Root Mean Square Error of Approximation = 0.046). Known-groups validity was also confirmed. Cronbach’s ɑ of all item clusters were greater than 0.9 and the median test-retest reliability coefficients of the 38 items were 0.85 (range = 0.71–0.91). In addition, the SRMs of PRO-CTCAE items were greater than 0.8, indicating strong responsiveness. Conclusion The simplified Chinese version of the PRO-CTCAE showed good reliability, validity, and responsiveness.
Background The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) have not been assessed. Therefore, we aimed to assess its validity, reliability, and responsiveness. Patients and methods A Chinese version of the PRO-CTCAE and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (QLQ-C30) were distributed to 1580 patients from four cancer hospitals in China. Validity assessments included construct validity, measured by Pearson's correlations and confirmatory factor analysis (CFA), and known-groups validity, measured by t-tests. The assessment of reliability included internal consistency, measured by Cronbach's É, and test-retest reliability, measured by the intraclass correlation (ICC). Responsiveness was assessed by standardized response means (SRMs). Results Data from 1555 patients who completed the instruments were analyzed. The correlations were high between PRO-CTCAE items and parallel QLQ-C30 symptom scales (r > 0.60, p < 0.001), except for fatigue (severity: r = 0.49). Moreover, CFA showed the PRO-CTCAE structure was a good fit with the data (Root Mean Square Error of Approximation = 0.046). Known-groups validity was also confirmed. Cronbach's É of all item clusters were greater than 0.9 and the median test-retest reliability coefficients of the 38 items were 0.85 (range = 0.71-0.91). In addition, the SRMs of PRO-CTCAE items were greater than 0.8, indicating strong responsiveness. Conclusion The simplified Chinese version of the PRO-CTCAE showed good reliability, validity, and responsiveness. Keywords: Patient-reported outcomes, PRO-CTCAE, Chinese, Validity, Reliability
Background The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) have not been assessed. Therefore, we aimed to assess its validity, reliability, and responsiveness. Patients and methods A Chinese version of the PRO-CTCAE and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (QLQ-C30) were distributed to 1580 patients from four cancer hospitals in China. Validity assessments included construct validity, measured by Pearson’s correlations and confirmatory factor analysis (CFA), and known-groups validity, measured by t-tests. The assessment of reliability included internal consistency, measured by Cronbach’s ɑ, and test-retest reliability, measured by the intraclass correlation (ICC). Responsiveness was assessed by standardized response means (SRMs). Results Data from 1555 patients who completed the instruments were analyzed. The correlations were high between PRO-CTCAE items and parallel QLQ-C30 symptom scales (r > 0.60, p < 0.001), except for fatigue (severity: r = 0.49). Moreover, CFA showed the PRO-CTCAE structure was a good fit with the data (Root Mean Square Error of Approximation = 0.046). Known-groups validity was also confirmed. Cronbach’s ɑ of all item clusters were greater than 0.9 and the median test-retest reliability coefficients of the 38 items were 0.85 (range = 0.71–0.91). In addition, the SRMs of PRO-CTCAE items were greater than 0.8, indicating strong responsiveness. Conclusion The simplified Chinese version of the PRO-CTCAE showed good reliability, validity, and responsiveness.
ArticleNumber 860
Audience Academic
Author Sun, Ying
Huang, Bo-Jie
Mao, Yan-Ping
Liu, Ying
Xie, Fang-Yun
Chen, Lei
Yang, Shan-Shan
Ma, Jun
Lu, Hai-Jun
Lin, Ai-Hua
Author_xml – sequence: 1
  givenname: Shan-Shan
  surname: Yang
  fullname: Yang, Shan-Shan
– sequence: 2
  givenname: Lei
  surname: Chen
  fullname: Chen, Lei
– sequence: 3
  givenname: Ying
  surname: Liu
  fullname: Liu, Ying
– sequence: 4
  givenname: Hai-Jun
  surname: Lu
  fullname: Lu, Hai-Jun
– sequence: 5
  givenname: Bo-Jie
  surname: Huang
  fullname: Huang, Bo-Jie
– sequence: 6
  givenname: Ai-Hua
  surname: Lin
  fullname: Lin, Ai-Hua
– sequence: 7
  givenname: Ying
  surname: Sun
  fullname: Sun, Ying
– sequence: 8
  givenname: Jun
  surname: Ma
  fullname: Ma, Jun
– sequence: 9
  givenname: Fang-Yun
  surname: Xie
  fullname: Xie, Fang-Yun
– sequence: 10
  givenname: Yan-Ping
  surname: Mao
  fullname: Mao, Yan-Ping
BookMark eNp9ktlq3DAUhk1JaZb2BXplKJT0wqk2y5qbQhi6BAKFbrfiWD6aUZCtqSSH5hX61NVkEpoJpehCOkff_2vhP64OpjBhVb2k5IxSJd8mypRqG8JoQ5SkpCFPqiMqOtowQbqDB-vD6jilK0Jop4h6Vh1ywWkrGD-qfv8A7waXb2qYhjqid9A7v62DrfMa6-TGjXfW4VAv127ChPUGssMpNxE3IeayEeZswoipvsaYXJjutaU5lipjHN0UfFjd1Ca6UjqobYg1DFsB1nhd7NLz6qkFn_DF3XxSff_w_tvyU3P5-ePF8vyyMZK0uZFgwSCxqETHekkk72zfo2GCW9UyIACokAjT95YDH7oOpVSAjHKlGAh-Ul3sfIcAV3oT3QjxRgdw-rYR4kpDzM541As-EGkoo2YwAnnfC9ZxCQtshWStHYrXu53XZu5HHEx5RwS_Z7q_M7m1XoVrrTgVrWLF4PTOIIafM6asR5cMeg8Thjlp1rbtQnYdaQv66hF6FeY4la8qVLlOJzld_KVWUB7gJhvKuWZrqs9lx7hQcrGlzv5BlTHg6EyJmXWlvyd4sycoTMZfeQVzSvri65d99vUDdo3g8zoFP-cSjbQPqh1oYkgpotXGZdhi5TbOa0r0Nuh6F3Rdgq5vg65JkbJH0vs__4_oD2JtAgA
CitedBy_id crossref_primary_10_1186_s12957_022_02679_y
crossref_primary_10_1016_j_ijrobp_2022_11_036
Cites_doi 10.1093/jnci/dju244
10.1080/10705519909540118
10.1007/s11136-013-0470-1
10.1093/jnci/dju129
10.1093/annonc/mdp542
10.1200/JCO.2014.57.9334
10.1016/j.jpainsymman.2020.01.015
10.1001/jamaoncol.2015.2639
10.1007/s00520-017-3764-y
10.1016/j.jpainsymman.2013.10.027
10.1056/NEJMp0911494
10.1016/j.jad.2020.04.060
10.1186/s12885-020-07631-5
10.1016/j.jval.2011.06.003
10.1186/s41687-017-0022-5
10.1093/jnci/85.5.365
10.1177/002224378101800104
10.1093/annonc/mdn417
10.1200/JCO.2007.12.4784
10.1093/annonc/mdw422
10.1016/S1470-2045(06)70910-X
10.1186/s41687-017-0012-7
10.1016/S0895-4356(99)00206-1
ContentType Journal Article
Copyright COPYRIGHT 2021 BioMed Central Ltd.
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021. The Author(s).
The Author(s) 2021
Copyright_xml – notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021. The Author(s).
– notice: The Author(s) 2021
DBID AAYXX
CITATION
ISR
3V.
7TO
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12885-021-08610-0
DatabaseName CrossRef
Gale In Context: Science
ProQuest Central (Corporate)
Oncogenes and Growth Factors Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Publicly Available Content
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Open Access Full Text
DatabaseTitle CrossRef
Publicly Available Content Database
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic





Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2407
EndPage 11
ExternalDocumentID oai_doaj_org_article_93d06c121cdc4e3bb42736a9e54625fd
PMC8314582
A672348699
10_1186_s12885_021_08610_0
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACMJI
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
IHW
INH
INR
ISR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
PMFND
3V.
7TO
7XB
8FK
AZQEC
DWQXO
H94
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c605t-6aface0fe8472b60637fbbec243f852a0aae8e04cbbf3a3d77e668ae213882a43
IEDL.DBID 7X7
ISSN 1471-2407
IngestDate Wed Aug 27 01:14:45 EDT 2025
Thu Aug 21 18:35:55 EDT 2025
Fri Jul 11 00:35:16 EDT 2025
Fri Jul 25 23:01:11 EDT 2025
Tue Jun 17 21:29:51 EDT 2025
Tue Jun 10 20:35:26 EDT 2025
Fri Jun 27 03:50:01 EDT 2025
Thu May 22 21:21:53 EDT 2025
Tue Jul 01 04:29:07 EDT 2025
Thu Apr 24 22:59:30 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c605t-6aface0fe8472b60637fbbec243f852a0aae8e04cbbf3a3d77e668ae213882a43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/2562576319?pq-origsite=%requestingapplication%
PMID 34315423
PQID 2562576319
PQPubID 44074
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_93d06c121cdc4e3bb42736a9e54625fd
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8314582
proquest_miscellaneous_2555967705
proquest_journals_2562576319
gale_infotracmisc_A672348699
gale_infotracacademiconefile_A672348699
gale_incontextgauss_ISR_A672348699
gale_healthsolutions_A672348699
crossref_citationtrail_10_1186_s12885_021_08610_0
crossref_primary_10_1186_s12885_021_08610_0
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-07-27
PublicationDateYYYYMMDD 2021-07-27
PublicationDate_xml – month: 07
  year: 2021
  text: 2021-07-27
  day: 27
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle BMC cancer
PublicationYear 2021
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References C Kkf (8610_CR12) 2020; 20
8610_CR2
E Basch (8610_CR6) 2010; 362
JL Hay (8610_CR11) 2014; 23
A Werner-Seidler (8610_CR30) 2020; 273
8610_CR7
BB Reeve (8610_CR13) 2014; 106
L CFaDF (8610_CR23) 1981; 18
E Basch (8610_CR4) 2006; 7
E Basch (8610_CR8) 2014; 106
JA Husted (8610_CR27) 2000; 53
JF Hair (8610_CR24) 2018
A Trotti (8610_CR1) 2007; 25
J Yoon (8610_CR17) 2020; 59
JP Woo (8610_CR22) 2012
AC Dueck (8610_CR9) 2015; 1
8610_CR28
T Miyaji (8610_CR10) 2017; 1
T Kawaguchi (8610_CR16) 2017; 2
R Knoerl (8610_CR31) 2017; 25
A Janice (8610_CR26) 2000; 53
NK Aaronson (8610_CR19) 1993; 85
M Di Maio (8610_CR5) 2015; 33
S Rolstad (8610_CR14) 2011; 14
JCBI Nunnally (8610_CR25) 1994
E Basch (8610_CR3) 2009; 20
V Hagelstein (8610_CR15) 2016; 27
L Hu (8610_CR21) 1999; 6
C Wan (8610_CR18) 2008; 19
J Cohen (8610_CR20) 1988
ST Dong (8610_CR29) 2014; 48
References_xml – volume: 106
  start-page: dju244
  issue: 9
  year: 2014
  ident: 8610_CR8
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/dju244
– volume: 6
  start-page: 1
  issue: 1
  year: 1999
  ident: 8610_CR21
  publication-title: Struct Equ Model Multidiscip J
  doi: 10.1080/10705519909540118
– volume: 23
  start-page: 257
  issue: 1
  year: 2014
  ident: 8610_CR11
  publication-title: Qual Life Res
  doi: 10.1007/s11136-013-0470-1
– volume: 106
  start-page: dju129
  issue: 7
  year: 2014
  ident: 8610_CR13
  publication-title: JNCI
  doi: 10.1093/jnci/dju129
– volume: 20
  start-page: 1905
  issue: 12
  year: 2009
  ident: 8610_CR3
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdp542
– ident: 8610_CR2
– volume: 33
  start-page: 910
  issue: 8
  year: 2015
  ident: 8610_CR5
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2014.57.9334
– volume: 59
  start-page: 1082
  issue: 5
  year: 2020
  ident: 8610_CR17
  publication-title: J Pain Symptom Manag
  doi: 10.1016/j.jpainsymman.2020.01.015
– volume: 1
  start-page: 1051
  issue: 8
  year: 2015
  ident: 8610_CR9
  publication-title: JAMA Oncol
  doi: 10.1001/jamaoncol.2015.2639
– volume: 25
  start-page: 3437
  issue: 11
  year: 2017
  ident: 8610_CR31
  publication-title: Support Care Cancer
  doi: 10.1007/s00520-017-3764-y
– volume-title: Statistical power analysis for the behavioral sciences
  year: 1988
  ident: 8610_CR20
– volume: 48
  start-page: 411
  issue: 3
  year: 2014
  ident: 8610_CR29
  publication-title: J Pain Symptom Manag
  doi: 10.1016/j.jpainsymman.2013.10.027
– volume: 362
  start-page: 865
  issue: 10
  year: 2010
  ident: 8610_CR6
  publication-title: N Engl J Med
  doi: 10.1056/NEJMp0911494
– volume: 273
  start-page: 106
  year: 2020
  ident: 8610_CR30
  publication-title: J Affect Disord
  doi: 10.1016/j.jad.2020.04.060
– volume: 20
  start-page: 1153
  issue: 1
  year: 2020
  ident: 8610_CR12
  publication-title: BMC Cancer
  doi: 10.1186/s12885-020-07631-5
– volume: 14
  start-page: 1101
  issue: 8
  year: 2011
  ident: 8610_CR14
  publication-title: Value Health
  doi: 10.1016/j.jval.2011.06.003
– ident: 8610_CR7
– ident: 8610_CR28
– volume: 2
  start-page: 2
  issue: 1
  year: 2017
  ident: 8610_CR16
  publication-title: J Patient Rep Outcomes
  doi: 10.1186/s41687-017-0022-5
– volume: 85
  start-page: 365
  issue: 5
  year: 1993
  ident: 8610_CR19
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/85.5.365
– volume: 18
  start-page: 39
  issue: 1
  year: 1981
  ident: 8610_CR23
  publication-title: J Mark Res
  doi: 10.1177/002224378101800104
– volume-title: Psychometric Theory.
  year: 1994
  ident: 8610_CR25
– volume: 19
  start-page: 2053
  issue: 12
  year: 2008
  ident: 8610_CR18
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdn417
– volume: 25
  start-page: 5121
  issue: 32
  year: 2007
  ident: 8610_CR1
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2007.12.4784
– volume-title: The concept and understanding of structural equation model
  year: 2012
  ident: 8610_CR22
– volume-title: C., Babin, B. J., and Anderson, R. E: multivariate data analysis, 8th edn
  year: 2018
  ident: 8610_CR24
– volume: 27
  start-page: 2294
  issue: 12
  year: 2016
  ident: 8610_CR15
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdw422
– volume: 7
  start-page: 903
  issue: 11
  year: 2006
  ident: 8610_CR4
  publication-title: The Lancet Oncology
  doi: 10.1016/S1470-2045(06)70910-X
– volume: 1
  start-page: 8
  issue: 1
  year: 2017
  ident: 8610_CR10
  publication-title: J Patient Rep Outcomes
  doi: 10.1186/s41687-017-0012-7
– volume: 53
  start-page: 459
  issue: 3
  year: 2000
  ident: 8610_CR26
  publication-title: J Clin Epidemiol
– volume: 53
  start-page: 459
  issue: 5
  year: 2000
  ident: 8610_CR27
  publication-title: J Clin Epidemiol
  doi: 10.1016/S0895-4356(99)00206-1
SSID ssj0017808
Score 2.3605647
Snippet Background The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for...
The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events...
Abstract Background The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria...
SourceID doaj
pubmedcentral
proquest
gale
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 1
SubjectTerms Cancer
Cancer therapies
Care and treatment
Chinese
Evaluation
Factor analysis
Hospitals
Methods
Outcome and process assessment (Health Care)
Patient-reported outcomes
Patients
PRO-CTCAE
Quality of life
Quantitative psychology
Questionnaires
Reliability
Terminology
Validity
SummonAdditionalLinks – databaseName: DOAJ Open Access Full Text
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEA-yB_EifuJzV40ieJCyaZMm6XEVl1VYD-rK3kKaD32wtLJ9T_Bf8K92JkkfWwW9eG0mpZ2ZzEdm8gshzxW4Bc6drmwdXCUi81XHbF0p22oEj2m6dL7i9L08ORPvztvzK1d9YU9YhgfOjDvsuGfS1U3tvBOB970AhyttF1oBoXv0aH3B583JVKkfKM30fERGy8MJrLDGk8i4HSix_LtwQwmt_0-b_Huf5BXHc3yL3CwRIz3KX3qbXAvDHXL9tNTE75KfnyGU9hBMUzt4ehku1hl6-wcdI4Xwjk5r7BqPEGtSvC07TIEWNNUqVwxgYNxuQPXCRL_n_bN5LjwEPaW5ZSbtwFMwM4jvbCmEu9Tifc7wwoQDNd0jZ8dvPr0-qcoNC5WDNGZTSRutCywG8FFND7kMV7EHqYL8om4by6wNOjDh-j5yy71SQUptQ1NziMyt4PfJ3jAO4QGhslER5CpFiF54pjvpuA8wRTswEdavSD0z3LgCP463YFyYlIZoabKQDAjJJCEZtiIvd3O-ZfCNv1K_QjnuKBE4Oz0AdTJFncy_1GlFnqAWmHwKdbf8zRGoLRdadt2KPEsUCJ4xYHfOF7udJvP244cF0YtCFEf4S2fLYQfgFeJtLSgPFpSwut1yeFZHU6zLZBrMWsEx1DD8dDeMM7FjbgjjFmkgV5RKsXZF1EKNFwxajgzrrwlhXPMa66kP_wdH98mNJi08VTXqgOxtLrfhEQRym_5xWrO_AOIYR4w
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELfGkBAviE9RGGAQEg8o4MSu7TwgNBDTQCoPQNHeLMcfW6Uq2ZoWsX-Bv5o7JykEpr3G5yb13fnu7LvfEfJcgVng3OnM5sFlIjKflczmmbJTjeAxRZnqK2af5eFcfDqaHu2Qod1Rv4DthaEd9pOar5avfp6dvwWFf5MUXsvXLeyxGuuM8bBP4uXuFXIVLJPCjgYz8edWQWmmh8KZC-eNjFPC8P9_p_43e_Ivc3Rwk9zo_Ui63zH-FtkJ9W1ybdbflN8hv76Dg-3Bxaa29nQVlosOkPucNpGC00fbBeaSR_BAKfbQDm2gPcZq1t0jwECzWYNAhpb-6E7VhrnwEKSXdok06VyewuaDqM-WghNMLXZ5hh9M6FDtXTI_-PDt_WHW913IHAQ360zaaF1gMYDlKiqIcLiKFfAauBr1tLDM2qADE66qIrfcKxWk1DYUOQd_3Qp-j-zWTR3uEyoLFYHbUoTohWe6lI77AFO0g43D-gnJhwU3rgclx94YS5OCEy1NxyQDTDKJSYZNyMvtnNMOkuNS6nfIxy0lwmmnB83q2PTaaUrumXR5kTvvROBVJcCrk7YMUwHxYYTPfIJSYLra1O2mYPZBmLnQsiwn5FmiQEiNGnN2ju2mbc3Hr19GRC96otjAv3S2L4GAtUIUrhHl3ogSdN6NhwdxNIPKmAJjWTAXOQw_3Q7jTMyjq0OzQRqIIKVSbDohaiTGowUaj9SLk4Q7rnmOt6wPLn_5Q3K9SCqlskLtkd31ahMegeO2rh4nbfwNoslCLA
  priority: 102
  providerName: Scholars Portal
Title Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events
URI https://www.proquest.com/docview/2562576319
https://www.proquest.com/docview/2555967705
https://pubmed.ncbi.nlm.nih.gov/PMC8314582
https://doaj.org/article/93d06c121cdc4e3bb42736a9e54625fd
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96B-KL-Imr5xpF8EHKtU02SZ_kVu44hT1k9WTxJaT5OBeO9tzuCv4L_tXOpNnVKtxLH5pJPzIfmUwmvyHklYRpgTGrMlN4m_GQu6zKTZFJM1EIHlNW8XzF7EycnvMPi8kiBdy6lFa5tYnRULvWYoz8sERPHZShqN5efc-wahTurqYSGjfJPkKXoVTLxW7BVUiVq-1BGSUOO7DFCs8jY1BQ4CbwYDKKmP3_W-Z_syX_mn5O7pI7yW-kRz2j75EbvrlPbs3SzvgD8usLONQOXGpqGkdX_nLZA3D_pG2g4OTRbom54wE8Too1s33nacJUzfp9A2hoN2sYDN_RH30UbdsXbsLv0z5xJsbhKRgbRHk2FJxearCqMzwwokF1D8n5yfHnd6dZqrOQWVjMrDNhgrE-Dx5mqrKGFQ2ToQbeAheDmpQmN8Yrn3Nb14EZ5qT0Qijjy4KBf244e0T2mrbxjwkVpQzAXcF9cNzlqhKWOQ9dlAVDYdyIFNsB1zaBkGMtjEsdFyNK6J5JGpikI5N0PiJvdn2uegiOa6mnyMcdJcJnxxvt6kInbdQVc7mwRVlYZ7lndc3BixOm8hMOUhbgM5-jFOj-LOrOCOgjEF7GlaiqEXkZKRBCo8EcnQuz6Tr9_tN8QPQ6EYUW_tKadOQBxgpRtwaUBwNK0HE7bN6Ko042ptN_NGJEXuyasSfmzTW-3SANrBiFlPlkRORAjAcDNGxplt8izrhiBe6qPrn-5U_J7TKqlMxKeUD21quNfwaO2roeR20ck_3p8dnH-TiGO-A64wqu8-nX314nQ4Q
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkYAL4imWFmoQiAOK6sRZ2zkgVB7VLu32AC3am-s4dlmpStrNLqh_gR_Db2TGSRYCUm-9xuMk9jz82Z4HIS8kLAucWxWZ2Nko9ayIMmbiSJqhwuQxSRbiKyYHYnSUfpoOp2vkVxcLg26VnU0MhrqoLJ6RbyeI1EEZ4uzt2XmEVaPwdrUrodGIxZ67-AFbtvrN-APw92WS7H48fD-K2qoCkQXovoiE8cY65h3Y5SQH_M6lz2Ek8M9eDRPDjHHKsdTmueeGF1I6IZRxScwBjZqUw3uvkeuw8DLc7MnpaoMXS8VUF5ijxHYNtl9h_DMeQgq8dO4tfqFGwP8rwb_emX8td7t3yO0Wp9KdRrDukjVX3iM3Ju1N_H3y8ysA-AIgPDVlQefudNYk_L6glacAKmk9Q191DwiXYo1uVzva5nCNmnsKaKiWC5h8V9Pvzald1xcewnTTxlEnnPtTMG6YVdpQANnUYBVpeGHIPlU_IEdXwoGHZL2sSveIUJFID9IkUueLtGAqE5YXDrooC4bJFAMSdxOubZv0HGtvnOqw-VFCN0zSwCQdmKTZgLxe9TlrUn5cSv0O-biixHTd4UE1P9Gt9uuMF0zYOIltYVPH8zwF1ChM5oYpSLWH39xCKdBN7OvK6OgdUBaeKpFlA_I8UGDKjhJ9gk7Msq71-MvnHtGrlshXMEpr2hALmCvM8tWj3OxRgk2x_eZOHHVr02r9RwMH5NmqGXuin17pqiXSwA5VSMmGAyJ7YtyboH5LOfsW8porHuMt7uPLP75Fbo4OJ_t6f3ywt0FuJUG9ZJTITbK-mC_dEwCJi_xp0ExKjq_aFPwGzm59cQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Validity+and+reliability+of+the+simplified+Chinese+patient-reported+outcomes+version+of+the+common+terminology+criteria+for+adverse+events&rft.jtitle=BMC+cancer&rft.au=Shan-Shan%2C+Yang&rft.au=Chen%2C+Lei&rft.au=Liu%2C+Ying&rft.au=Hai-Jun%2C+Lu&rft.date=2021-07-27&rft.pub=BioMed+Central&rft.eissn=1471-2407&rft.volume=21&rft.spage=1&rft_id=info:doi/10.1186%2Fs12885-021-08610-0
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2407&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2407&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2407&client=summon